Harvard Bioscience
HBIO • NASDAQ
Harvard Bioscience is a medical - instruments & supplies company in the healthcare sector trading on NASDAQ, led by CEO John Duke, with a market cap of $24.0M.
Market Cap$24.0M
Employees416.0
CEOJohn Duke
CountryUnited States of America
Healthcare
Medical - Instruments & Supplies
Next EarningsMay 11, 2026 · In 4 weeksQ1 2026
Financials
Harvard Bioscience FAQ
Common questions about Harvard Bioscience
Harvard Bioscience is scheduled to report earnings for Q1 2026 on May 11, 2026. Analysts estimate revenue of $21.0M.
Harvard Bioscience has approximately 416 employees.